20/20 Biolabs, Inc
Price
FilingsNewest: 8-K, Shareholder voteSep 18 →InsidersNo open-market buys or sales.→HoldersCresset 2.0%Vanguard Fiduciary Trust 0.4%Geode 0.4%→PeersClosest companies: BIAF, IMDX, CDIO→
From the filings
Figures
- Revenue
- $1.8Mlast 12 months
- Net income
- −$5.1Mlast 12 months
- Operating cash flow
- −$2.7Mlast 12 months
- Cash and equivalents
- $4.5Mat the last balance sheet
- Shares outstanding
- 12.3M shareson issue